Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up0.55% Nasdaq Up0.29%

Amarin Corporation plc (AMRN)

1.53 0.08(4.97%) Apr 15, 4:00PM EDT
Get the big picture on all your investments.
ProfileGet Profile for:
Amarin Corporation plc
2 Pembroke House
Upper Pembroke Street 28-32
Dublin, 2
Ireland - Map
Phone: 353 1 669 9020

Index Membership:N/A
Industry:Drug Manufacturers - Other
Full Time Employees:185

Business Summary 

Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases in the United States. It develops products in the areas of lipid science and therapeutic benefits of polyunsaturated fatty acids. The company markets Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It is also developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Amarin Corporation plc

Key Executives 
Mr. John F. Thero , 53
Chief Exec. Officer, Pres, Assistant Sec. and Director
Mr. Joseph T. Kennedy J.D., 46
Chief Compliance Officer, Sr. VP, Gen. Counsel and Sec.
Dr. Paresh Soni , 53
Head of Devel. and Sr. VP
Dr. Steven B. Ketchum Ph.D., 49
Sr. VP and Pres of R&D
Mr. Patrick J. O'Sullivan , 72
Director and Member of Audit Committee
Amounts are as of Dec 31, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders